StockStory Favors Eli Lilly and Moody’s, Questions Nordson
The publisher cited revenue growth and other measures for its two favored stocks, while pointing to weaker growth and returns at Nordson.
Makkler Newsroom · Oct 12, 06:45 PM · 1 min read
Market closed· · USD · Data may be delayed
Avg. target $361.00 (+11.2%)
Prices may be delayed and are for informational purposes only - not investment advice.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.